The device was not returned for analysis.The lot history record (lhr) and similar incident reviews were not performed because no lot information was provided.Based on available information and due to the limited information available from the article, the cause of the reported heart failure, renal failure, hemorrhage, and recurrent mr were unable to be determined.The reported patient effects of heart failure, hemorrhage, mitral regurgitation, and renal failure, as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.The reported unexpected medical intervention and hospitalization were results of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.Date of event is estimated.The udi number is not known as the part and lot numbers were not provided.The implant date is estimated.Attachment: article titled ¿impact of extra-mitral valve cardiac involvement in patients with primary mitral regurgitation undergoing transcatheter edge-to-edge repair.¿.
|
It was reported through a research article that 654 patients underwent transcatheter edge-to-edge repair (teer) from (b)(6) 2020.Within two years of the procedure, the implanted mitraclips may have caused or contributed to recurrent mitral regurgitation, acute heart failure, acute kidney injury, bleeding, intervention to implant an additional mitraclip, and rehospitalization.Additional information is listed in the attached article, ¿impact of extra-mitral valve cardiac involvement in patients with primary mitral regurgitation undergoing transcatheter edge-to-edge repair.¿.
|